Some longtime advocates of the therapy say they’re pessimistic about its future. This is a Kaiser Health News story. Six months after it was controversially hailed by Trump administration officials as ...

LOS ANGELES (KABC) -- Long before vaccines, the focus was on a handful of COVID-19 treatments that provided glimmers of hope. The first to emerge was convalescent plasma. It offered a way for ...

Convalescent plasma is a way of artificially inducing passive immunity by transferring blood plasma from patients who have had a disease to naïve patients. This can then grant the recipient immunity ...

Findings from a nationwide, multicenter study led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health suggest that patients with COVID-19 have less chance of developing ...

Passive immunization with plasma collected from convalescent patients has been regularly used to treat coronavirus disease 2019 (Covid-19). Minimal data are available regarding the use of convalescent ...

It's been a few months since the world was focused on convalescent plasma – the idea that the antibody-rich plasma extracted from the blood from recovered Covid-19 patients could help treat the sick.

Convalescent plasma – a once-celebrated treatment for Covid-19 that has largely fallen out of favor – does work well for people who are immune-compromised, according to a study published Thursday. The ...

Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19) under the presumption that such plasma contains potentially therapeutic antibodies to severe acute respiratory ...

There is no solid evidence for or against recommending convalescent plasma to treat patients hospitalized with COVID-19, a government panel said Tuesday, less than 10 days after the Food and Drug ...